<DOC>
	<DOCNO>NCT02996084</DOCNO>
	<brief_summary>The primary objective study determine normative range brain volume brain volume change healthy control ( HC ) participant whose age , race , gender distribution approximately match age , race , gender distribution patient Multiple Sclerosis ( MS ) enrol Study 888MS001 . The secondary objective use result primary endpoint ensure consistency brain volume measurement across MS PATHS center .</brief_summary>
	<brief_title>MS PATHS Normative Sub-Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Key Inclusion Criteria Ability understand purpose risk study provide sign date informed consent authorization use protect health information accordance national local participant privacy regulation . Key Exclusion Criteria History human immunodeficiency virus . Confirmed suspect pregnancy . Diagnosis migraine require medication participantreported diagnosis neurological disease condition ( e.g. , stroke , transient ischemic attack , epilepsy , brain infection , brain surgery , prior head injury concussion , brain tumor ) . Any participantreported diagnosis autoimmune disorder ( e.g. , rheumatoid arthritis , Sj√∂gren 's syndrome , scleroderma , systemic lupus erythematosus ) . Standard MRI exclusion criterion , include claustrophobia , inability lay still magnet ( e.g. , tremor ) , type implant metal body would affect strong magnetic field . NOTE : Other protocol define Inclusion/Exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Imaging research</keyword>
</DOC>